Bariatric surgery has been associated with increased metabolic kidney
stone risk and post-operative stone formation. A MEDLINE search, performed for
articles published between January 2005 and November 2013, identified 24
pertinent studies containing 683 bariatric patients with 24-hour urine profiles,
6,777 bariatric patients with kidney stone incidence, and 7,089 non-stone
forming controls. Of all procedures reviewed, only Roux-en-Y gastric bypass
(RYGB) was linked to post-operative kidney stone development, increasing stone
incidence two-fold in non-stone formers (8.5%) and four-fold in patients
with previous stone history (16.7%). High quality evidence from 7
studies (n=277 patients) before and after RYGB identified the following
post-RYGB urinary lithogenic risk factors: 30% reduction in urine volume
(the main driver of urinary crystal saturation), 40% reduction in
urinary citrate (a potent stone inhibitor), and 50% increase in urinary
oxalate (a stone promotor). Based on this, a summary of strategies to reduce
calcium oxalate stone risk following RYGB is provided. Furthermore, recent
experimental RYGB studies are assessed for insights into the pathophysiology of
oxalate handling, and the literature in gut anion (oxalate) transport is
reviewed. Finally, as a potential probiotic therapy for hyperoxaluria, primary
data from our laboratory is presented, demonstrating a 70% reduction in
urinary oxalate levels in four experimental RYGB animals after colonization with
Oxalobacter formigines, a non-pathogenic gut commensal that
uses oxalate as an energy source.
Overall, urine profiles and kidney stone risk following bariatric surgery
appear modifiable by dietary adjustments, appropriate supplementation, and
lifestyle changes. For hyperoxaluria resistant to dietary oxalate restriction
and calcium binding, well-designed human investigations are needed to identify
additional means of lowering urinary oxalate, such as
Oxalobacter colonization or empiric pyridoxine therapy.
Further investigations are also needed to determine tolerability and compliance
of stone prevention strategies, such as citrate supplementation and hydration,
in this population.